Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Barrett

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
MC-207110 Daiichi Seiyaku/Microcide PharmaceuticalsJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Moxifloxacin BayerJ F Barrett
Expert Opinion on Pharmacotherapy|May 5, 2001
Antimicrobial resistance--should we be concerned?J F Barrett
Expert Opinion on Investigational Drugs|February 24, 2001
SMI's 2nd Annual Superbugs and Superdrugs Conference: innovations in anti-infectivesJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Oritavancin. Eli Lilly & CoJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Linezolid Pharmacia CorpJ F Barrett
Idrugs : the Investigational Drugs Journal|July 23, 2005
Antifungal agents and efflux pump inhibitorsS Arikan, J F Barrett
Analytical Biochemistry|November 1, 1986
Renaturation of dextranase activity from culture supernatant fluids of Streptococcus sobrinus after sodium dodecylsulfate polyacrylamide gel electrophoresisJ F Barrett, R Curtiss
Expert Opinion on Investigational Drugs|July 5, 2005
Importance of antifungal drug-resistance: clinical significance and need for novel therapyM Frosco, J F Barrett
Idrugs : the Investigational Drugs Journal|August 23, 2005
Quinolone updateJ F Barrett, L E Lawrence
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
MC-207110 Daiichi Seiyaku/Microcide PharmaceuticalsJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Moxifloxacin BayerJ F Barrett
Expert Opinion on Pharmacotherapy|May 5, 2001
Antimicrobial resistance--should we be concerned?J F Barrett
Expert Opinion on Investigational Drugs|February 24, 2001
SMI's 2nd Annual Superbugs and Superdrugs Conference: innovations in anti-infectivesJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Oritavancin. Eli Lilly & CoJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Linezolid Pharmacia CorpJ F Barrett
Idrugs : the Investigational Drugs Journal|July 23, 2005
Antifungal agents and efflux pump inhibitorsS Arikan, J F Barrett
Analytical Biochemistry|November 1, 1986
Renaturation of dextranase activity from culture supernatant fluids of Streptococcus sobrinus after sodium dodecylsulfate polyacrylamide gel electrophoresisJ F Barrett, R Curtiss
Expert Opinion on Investigational Drugs|July 5, 2005
Importance of antifungal drug-resistance: clinical significance and need for novel therapyM Frosco, J F Barrett
Idrugs : the Investigational Drugs Journal|August 23, 2005
Quinolone updateJ F Barrett, L E Lawrence
Pageof 11